Longboard Non Currrent Assets Other vs Net Working Capital Analysis
| LBPH Stock | USD 20.69 0.18 0.88% |
Longboard Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Longboard Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Longboard Pharmaceuticals is a good investment. Please check the relationship between Longboard Pharmaceuticals Non Currrent Assets Other and its Net Working Capital accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Longboard Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.
Non Currrent Assets Other vs Net Working Capital
Non Currrent Assets Other vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Longboard Pharmaceuticals Non Currrent Assets Other account and Net Working Capital. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Longboard Pharmaceuticals' Non Currrent Assets Other and Net Working Capital is -0.39. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Longboard Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Longboard Pharmaceuticals' Non Currrent Assets Other and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Longboard Pharmaceuticals are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Non Currrent Assets Other i.e., Longboard Pharmaceuticals' Non Currrent Assets Other and Net Working Capital go up and down completely randomly.
Correlation Coefficient | -0.39 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Net Working Capital
Most indicators from Longboard Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Longboard Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Longboard Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.The Longboard Pharmaceuticals' current Issuance Of Capital Stock is estimated to increase to about 38.5 M, while Selling General Administrative is projected to decrease to under 11.3 M.
Longboard Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Longboard Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether Longboard Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Longboard Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Longboard Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Longboard Pharmaceuticals Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Longboard Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Longboard Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.25) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.